SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001991925-23-000005
Filing Date
2023-09-18
Accepted
2023-09-18 16:32:12
Documents
1
Period of Report
2023-09-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6145
  Complete submission text file 0001991925-23-000005.txt   7941
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2828 BATHURST ST #400 TORONTO A6 M6B3A7
Business Address 2828 BATHURST ST #400 TORONTO A6 M6B3A7 4164537832
Symetryx Corp (Reporting) CIK: 0001991925 (see all company filings)

State of Incorp.: A6 | Fiscal Year End: 0531
Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 231261556